OvaScience Stock Price, News & Analysis (NASDAQ:OVAS)

$0.95 -0.04 (-4.04 %)
(As of 02/19/2018 11:13 AM ET)
Previous Close$0.99
Today's Range$0.95 - $1.00
52-Week Range$0.90 - $2.05
Volume139,700 shs
Average Volume835,842 shs
Market Capitalization$34.19 million
P/E Ratio-0.52
Dividend YieldN/A
Beta3.13

About OvaScience (NASDAQ:OVAS)

OvaScience logoOvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's own ovarian tissue. The Company's AUGMENT treatment is designed to improve egg health by supplementing a mitochondrial deficiency. With the AUGMENT treatment, energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs during the in vitro fertilization process to supplement the existing mitochondria. Its OvaPrime treatment is a fertility treatment designed to replenish a woman's ovary by increasing her egg reserve using her own EggPC cells. Its OvaTure treatment is a fertility treatment that seeks to create mature fertilizable eggs in vitro from a woman's own EggPC cells without the need for hormone hyperstimulation.

Receive OVAS News and Ratings via Email

Sign-up to receive the latest news and ratings for OVAS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:OVAS
CUSIPN/A
Phone617-500-2802

Debt

Debt-to-Equity RatioN/A
Current Ratio8.72%
Quick Ratio8.72%

Price-To-Earnings

Trailing P/E Ratio-0.523169398907104
Forward P/E Ratio-0.64
P/E GrowthN/A

Sales & Book Value

Annual Sales$650,000.00
Price / Sales52.19
Cash FlowN/A
Price / CashN/A
Book Value$3.04 per share
Price / Book0.31

Profitability

Trailing EPS($1.83)
Net Income$-82,250,000.00
Net Margins-20,090.13%
Return on Equity-68.71%
Return on Assets-60.49%

Miscellaneous

Employees118
Outstanding Shares35,710,000

OvaScience (NASDAQ:OVAS) Frequently Asked Questions

What is OvaScience's stock symbol?

OvaScience trades on the NASDAQ under the ticker symbol "OVAS."

How were OvaScience's earnings last quarter?

OvaScience Inc (NASDAQ:OVAS) announced its quarterly earnings results on Thursday, November, 3rd. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.62) by $0.08. The biotechnology company had revenue of $0.02 million for the quarter, compared to the consensus estimate of $0.25 million. OvaScience had a negative return on equity of 68.71% and a negative net margin of 20,090.13%. The business's revenue was down 73.3% compared to the same quarter last year. During the same period last year, the business posted ($0.66) EPS. View OvaScience's Earnings History.

When will OvaScience make its next earnings announcement?

OvaScience is scheduled to release their next quarterly earnings announcement on Thursday, March, 1st 2018. View Earnings Estimates for OvaScience.

Where is OvaScience's stock going? Where will OvaScience's stock price be in 2018?

3 brokers have issued 1-year price targets for OvaScience's stock. Their forecasts range from $1.00 to $15.00. On average, they anticipate OvaScience's share price to reach $8.00 in the next year. View Analyst Ratings for OvaScience.

Who are some of OvaScience's key competitors?

Who are OvaScience's key executives?

OvaScience's management team includes the folowing people:

  • Christopher A. Kroeger M.D., Chief Executive Officer
  • Jonathan Gillis, principal Financial Officer, principal Accounting Officer, Vice President
  • Karen Long, Executive Vice President - Clinical and Regulatory Affairs and Quality Assurance
  • James Luterman Ph.D., Executive Vice President - Research and Development
  • Theresa McNeely, Executive Vice President, Chief Communications Officer (Age 51)
  • James Lillie, Chief Scientific Officer
  • Ravi Mehrotra Ph.D., Chief Corporate Development Officer
  • Richard H. Aldrich, Lead Independent Director (Age 62)
  • John P. Howe III M.D., Director (Age 67)
  • John E. Sexton Ph.D., Director

Who owns OvaScience stock?

OvaScience's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (2.19%), Deutsche Bank AG (1.45%), Millennium Management LLC (0.81%) and Two Sigma Investments LP (0.68%). Company insiders that own OvaScience stock include Michelle Dipp, Paul WD Chapman and Richard Aldrich. View Institutional Ownership Trends for OvaScience.

Who sold OvaScience stock? Who is selling OvaScience stock?

OvaScience's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC. View Insider Buying and Selling for OvaScience.

Who bought OvaScience stock? Who is buying OvaScience stock?

OvaScience's stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Deutsche Bank AG and Two Sigma Investments LP. Company insiders that have bought OvaScience stock in the last two years include Michelle Dipp, Paul WD Chapman and Richard Aldrich. View Insider Buying and Selling for OvaScience.

How do I buy OvaScience stock?

Shares of OvaScience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OvaScience's stock price today?

One share of OvaScience stock can currently be purchased for approximately $0.95.

How big of a company is OvaScience?

OvaScience has a market capitalization of $34.19 million and generates $650,000.00 in revenue each year. The biotechnology company earns $-82,250,000.00 in net income (profit) each year or ($1.83) on an earnings per share basis. OvaScience employs 118 workers across the globe.

How can I contact OvaScience?

OvaScience's mailing address is 9 FOURTH AVENUE, WALTHAM MA, 02451. The biotechnology company can be reached via phone at 617-500-2802 or via email at [email protected]


MarketBeat Community Rating for OvaScience (OVAS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  197 (Vote Outperform)
Underperform Votes:  171 (Vote Underperform)
Total Votes:  368
MarketBeat's community ratings are surveys of what our community members think about OvaScience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

OvaScience (NASDAQ:OVAS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.00$8.00$8.00$8.00
Price Target Upside: 429.80% upside429.80% upside429.80% upside379.04% upside

OvaScience (NASDAQ:OVAS) Consensus Price Target History

Price Target History for OvaScience (NASDAQ:OVAS)

OvaScience (NASDAQ:OVAS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/6/2017HC WainwrightReiterated RatingBuy$15.00N/AView Rating Details
8/3/2017OppenheimerReiterated RatingHoldLowView Rating Details
4/18/2017Credit Suisse GroupReiterated RatingUnderperform -> Underperform$1.00LowView Rating Details
8/10/2016JMP SecuritiesReiterated RatingNeutralN/AView Rating Details
8/5/2016JPMorgan Chase & Co.Lower Price TargetNeutral$9.00 -> $8.00N/AView Rating Details
5/8/2016Leerink SwannReiterated RatingHold$6.00 -> $7.00N/AView Rating Details
3/21/2016S&P Equity ResearchLower Price Target$10.82 -> $8.83N/AView Rating Details
(Data available from 2/19/2016 forward)

Earnings

OvaScience (NASDAQ:OVAS) Earnings History and Estimates Chart

Earnings by Quarter for OvaScience (NASDAQ:OVAS)

OvaScience (NASDAQ OVAS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018($0.28)N/AView Earnings Details
11/2/2017Q3 2017($0.40)($0.25)$0.09 million$0.06 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.47)($0.45)$0.09 million$0.08 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.46)($0.38)$0.12 million$0.06 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.58)($0.64)$0.11 million$0.12 millionViewListenView Earnings Details
11/3/2016Q316($0.62)($0.54)$0.25 million$0.02 millionViewListenView Earnings Details
8/4/2016Q216($0.78)($0.62)$0.21 million$0.19 millionViewListenView Earnings Details
5/5/2016Q116($0.72)($0.80)$0.14 million$0.15 millionViewListenView Earnings Details
2/25/2016Q315($0.71)($0.76)$0.20 million$0.16 millionViewListenView Earnings Details
11/5/2015Q3($0.68)($0.66)$0.17 million$0.08 millionViewN/AView Earnings Details
8/10/2015Q215($0.64)($0.64)$0.57 million$0.03 millionViewN/AView Earnings Details
5/11/2015($0.65)($0.65)$0.40 million$0.02 millionViewN/AView Earnings Details
3/16/2015Q414($0.59)($0.79)ViewN/AView Earnings Details
11/10/2014Q314($0.44)($0.54)ViewN/AView Earnings Details
8/7/2014Q214($0.45)($0.42)ViewN/AView Earnings Details
5/8/2014($0.46)($0.41)ViewN/AView Earnings Details
2/27/2014Q413($0.39)($0.64)ViewN/AView Earnings Details
11/13/2013Q313($0.35)($0.40)ViewN/AView Earnings Details
8/13/2013Q213($0.28)($0.36)ViewN/AView Earnings Details
5/15/2013Q1 2013($0.28)($0.39)ViewN/AView Earnings Details
2/25/2013Q4 2012($0.29)($0.33)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

OvaScience (NASDAQ:OVAS) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.48 EPS
Next Year EPS Consensus Estimate: $-1.11 EPS

Dividends

Dividend History for OvaScience (NASDAQ:OVAS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

OvaScience (NASDAQ OVAS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.50%
Institutional Ownership Percentage: 54.42%
Insider Trades by Quarter for OvaScience (NASDAQ:OVAS)
Insider Trades by Quarter for OvaScience (NASDAQ:OVAS)

OvaScience (NASDAQ OVAS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2016Michelle DippCEOBuy425,000$7.00$2,975,000.00971,921View SEC Filing  
5/18/2016Michelle DippCEOBuy20,000$7.86$157,200.00971,921View SEC Filing  
5/17/2016Michelle DippCEOBuy40,000$7.63$305,200.00971,921View SEC Filing  
5/13/2016Richard AldrichDirectorBuy36,095$6.94$250,499.30604,185View SEC Filing  
5/11/2016Richard AldrichDirectorBuy20,000$7.64$152,800.00604,185View SEC Filing  
5/10/2016Michelle DippCEOBuy19,900$7.72$153,628.00971,921View SEC Filing  
5/10/2016Paul W.D. ChapmanCOOBuy3,100$7.37$22,847.003,100View SEC Filing  
3/24/2016Michelle DippCEOBuy59,800$9.49$567,502.00971,921View SEC Filing  
3/22/2016Michelle DippCEOBuy59,800$10.44$624,312.00971,921View SEC Filing  
3/18/2016Michelle DippCEOBuy59,700$8.26$493,122.00971,921View SEC Filing  
3/16/2016Michelle DippCEOBuy59,029$7.90$466,329.10971,921View SEC Filing  
3/14/2016Michelle DippCEOBuy162,732$7.60$1,236,763.20971,921View SEC Filing  
10/5/2015Jeffrey E YoungCFOBuy3,450$10.70$36,915.003,750View SEC Filing  
10/5/2015Marc D KozinDirectorBuy4,800$10.79$51,792.0020,553View SEC Filing  
9/9/2015Mary FisherDirectorBuy6,100$16.49$100,589.006,415View SEC Filing  
9/8/2015Marc D KozinDirectorBuy3,000$17.60$52,800.0014,612View SEC Filing  
4/8/2015Marc D KozinDirectorBuy3,000$28.45$85,350.00View SEC Filing  
4/2/2015Michelle DippCEOBuy1,000$32.49$32,490.00View SEC Filing  
1/13/2015Thomas MalleyDirectorBuy35,000$50.00$1,750,000.00View SEC Filing  
7/7/2014Richard AldrichDirectorBuy2,000$9.49$18,980.00View SEC Filing  
6/30/2014Richard AldrichDirectorBuy2,000$9.16$18,320.00View SEC Filing  
6/23/2014Richard AldrichDirectorBuy2,000$8.81$17,620.00View SEC Filing  
6/16/2014Richard AldrichDirectorBuy2,000$8.52$17,040.00View SEC Filing  
6/9/2014Richard AldrichDirectorBuy2,000$7.59$15,180.00View SEC Filing  
6/3/2014Harald F StockDirectorBuy1,063$7.01$7,451.63View SEC Filing  
6/2/2014Richard AldrichDirectorBuy2,000$7.29$14,580.00View SEC Filing  
5/27/2014Richard AldrichDirectorBuy2,000$7.50$15,000.00View SEC Filing  
5/20/2014Harald F StockDirectorBuy1,050$7.13$7,486.50View SEC Filing  
5/19/2014Richard AldrichDirectorBuy2,000$7.33$14,660.00View SEC Filing  
3/7/2014Fund L.P. LongwoodMajor ShareholderBuy100,000$10.00$1,000,000.00View SEC Filing  
9/12/2013Arthur TzianabosInsiderBuy1,000$10.32$10,320.00View SEC Filing  
9/12/2013Harald F StockDirectorBuy4,500$10.64$47,880.00View SEC Filing  
9/11/2013Christopher A BleckInsiderBuy2,000$11.15$22,300.00View SEC Filing  
9/11/2013Richard AldrichDirectorBuy4,850$10.54$51,119.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

OvaScience (NASDAQ OVAS) News Headlines

Source:
DateHeadline
Zacks: Brokerages Expect OvaScience Inc (OVAS) Will Post Quarterly Sales of $80,000.00Zacks: Brokerages Expect OvaScience Inc (OVAS) Will Post Quarterly Sales of $80,000.00
www.americanbankingnews.com - February 11 at 1:48 AM
 Analysts Anticipate OvaScience Inc (OVAS) Will Announce Earnings of -$0.29 Per Share Analysts Anticipate OvaScience Inc (OVAS) Will Announce Earnings of -$0.29 Per Share
www.americanbankingnews.com - February 9 at 9:08 PM
Why OvaScience Inc (NASDAQ:OVAS) Is A Financially Healthy CompanyWhy OvaScience Inc (NASDAQ:OVAS) Is A Financially Healthy Company
finance.yahoo.com - February 1 at 9:57 AM
Form 3 OvaScience, Inc. For: Jan 16 Filed by: Lillie James Woodruff - StreetInsider.comForm 3 OvaScience, Inc. For: Jan 16 Filed by: Lillie James Woodruff - StreetInsider.com
www.streetinsider.com - January 24 at 8:12 AM
 Brokerages Expect OvaScience Inc (OVAS) to Post -$0.29 Earnings Per Share Brokerages Expect OvaScience Inc (OVAS) to Post -$0.29 Earnings Per Share
www.americanbankingnews.com - January 23 at 11:06 PM
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018
finance.yahoo.com - January 22 at 3:59 PM
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018
finance.yahoo.com - January 18 at 11:30 AM
OVAS INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of OvaScience, Inc. Investors and Encourages Investors to ...OVAS INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of OvaScience, Inc. Investors and Encourages Investors to ...
www.businesswire.com - January 17 at 4:35 PM
OVAS INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of OvaScience, Inc. Investors and Encourages Investors to Contact the FirmOVAS INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of OvaScience, Inc. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - January 17 at 4:35 PM
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the Firm Before January 22, 2018Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the Firm Before January 22, 2018
finance.yahoo.com - January 17 at 10:18 AM
Financial Survey: OvaScience (OVAS) vs. Chromadex (CDXC)Financial Survey: OvaScience (OVAS) vs. Chromadex (CDXC)
www.americanbankingnews.com - January 15 at 3:32 AM
OvaScience (OVAS) and The Competition Financial ComparisonOvaScience (OVAS) and The Competition Financial Comparison
www.americanbankingnews.com - January 14 at 5:28 AM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018
finance.yahoo.com - January 12 at 4:25 PM
OvaScience (OVAS) Upgraded to "Buy" by Zacks Investment ResearchOvaScience (OVAS) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - January 10 at 6:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the Firm
finance.yahoo.com - January 9 at 10:17 AM
OvaScience Inc (OVAS) Expected to Post Quarterly Sales of $80,000.00OvaScience Inc (OVAS) Expected to Post Quarterly Sales of $80,000.00
www.americanbankingnews.com - January 8 at 7:02 AM
 Brokerages Expect OvaScience Inc (OVAS) Will Announce Earnings of -$0.29 Per Share Brokerages Expect OvaScience Inc (OVAS) Will Announce Earnings of -$0.29 Per Share
www.americanbankingnews.com - January 6 at 7:14 PM
Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVASPomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS
www.finanznachrichten.de - January 5 at 4:15 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline – January 22, 2018SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline – January 22, 2018
finance.yahoo.com - January 5 at 10:34 AM
OvaScience (OVAS) versus Its Peers Critical SurveyOvaScience (OVAS) versus Its Peers Critical Survey
www.americanbankingnews.com - January 4 at 11:06 PM
Recros Medica Closes $9M Financing, Strengthens BoardRecros Medica Closes $9M Financing, Strengthens Board
finance.yahoo.com - January 4 at 10:20 AM
Announces Corporate Update - Business Wire (press release)Announces Corporate Update - Business Wire (press release)
www.businesswire.com - January 3 at 4:34 PM
OvaScienceSM Announces Corporate UpdateOvaScienceSM Announces Corporate Update
finance.yahoo.com - January 3 at 4:34 PM
Head to Head Review: OvaScience (OVAS) & The CompetitionHead to Head Review: OvaScience (OVAS) & The Competition
www.americanbankingnews.com - January 2 at 9:14 PM
Critical Comparison: OvaScience (OVAS) and Its RivalsCritical Comparison: OvaScience (OVAS) and Its Rivals
www.americanbankingnews.com - January 1 at 3:28 AM
OvaScience (OVAS) vs. The Competition Financial SurveyOvaScience (OVAS) vs. The Competition Financial Survey
www.americanbankingnews.com - December 31 at 10:06 PM
Head to Head Contrast: OvaScience (OVAS) versus Its RivalsHead to Head Contrast: OvaScience (OVAS) versus Its Rivals
www.americanbankingnews.com - December 26 at 9:24 AM
Oncobiologics (ONS) & OvaScience (OVAS) Critical SurveyOncobiologics (ONS) & OvaScience (OVAS) Critical Survey
www.americanbankingnews.com - December 24 at 3:54 AM
OvaScience Inc. (OVAS) Expected to Post Quarterly Sales of $80,000.00OvaScience Inc. (OVAS) Expected to Post Quarterly Sales of $80,000.00
www.americanbankingnews.com - December 23 at 8:30 AM
Analyzing OvaScience (OVAS) & Its RivalsAnalyzing OvaScience (OVAS) & Its Rivals
www.americanbankingnews.com - December 23 at 3:07 AM
Head-To-Head Comparison: OvaScience (OVAS) vs. The CompetitionHead-To-Head Comparison: OvaScience (OVAS) vs. The Competition
www.americanbankingnews.com - December 21 at 9:28 AM
Financial Review: OvaScience (OVAS) & Infinity Pharmaceuticals (INFI)Financial Review: OvaScience (OVAS) & Infinity Pharmaceuticals (INFI)
www.americanbankingnews.com - December 20 at 11:28 AM
IMPORTANT OVASCIENCE, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in OvaScience, Inc.IMPORTANT OVASCIENCE, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in OvaScience, Inc.
finance.yahoo.com - December 20 at 10:27 AM
OvaScience (OVAS) and The Competition Critical SurveyOvaScience (OVAS) and The Competition Critical Survey
www.americanbankingnews.com - December 18 at 11:50 AM
EQUITY ALERT: Rosen Law Firm Announces Investigation of Claims Against OvaScience, Inc.EQUITY ALERT: Rosen Law Firm Announces Investigation of Claims Against OvaScience, Inc.
finance.yahoo.com - December 15 at 4:47 PM
Robbins Arroyo LLP: OvaScience, Inc. (OVAS) Misled Shareholders According to a Recently Filed Class ActionRobbins Arroyo LLP: OvaScience, Inc. (OVAS) Misled Shareholders According to a Recently Filed Class Action
finance.yahoo.com - December 5 at 12:06 PM
Zacks: Analysts Expect OvaScience Inc. (OVAS) Will Announce Quarterly Sales of $80,000.00Zacks: Analysts Expect OvaScience Inc. (OVAS) Will Announce Quarterly Sales of $80,000.00
www.americanbankingnews.com - December 5 at 6:22 AM
 Analysts Anticipate OvaScience Inc. (OVAS) to Announce -$0.29 EPS Analysts Anticipate OvaScience Inc. (OVAS) to Announce -$0.29 EPS
www.americanbankingnews.com - December 3 at 1:32 PM
IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a ... - GlobeNewswire (press release)IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a ... - GlobeNewswire (press release)
globenewswire.com - December 1 at 5:40 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS - PR Newswire (press release)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS - PR Newswire (press release)
www.prnewswire.com - December 1 at 5:40 PM
IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in OvaScience, Inc.IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in OvaScience, Inc.
finance.yahoo.com - November 30 at 4:31 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVASSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS
finance.yahoo.com - November 29 at 4:44 PM
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against OvaScience, Inc.Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against OvaScience, Inc.
finance.yahoo.com - November 29 at 10:31 AM
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the Firm
finance.yahoo.com - November 29 at 10:31 AM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience ... - PR Newswire (press release)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience ... - PR Newswire (press release)
www.prnewswire.com - November 28 at 10:30 AM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018
finance.yahoo.com - November 27 at 4:39 PM
OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding ... - GlobeNewswire (press release)OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding ... - GlobeNewswire (press release)
globenewswire.com - November 23 at 7:15 AM
OvaScience Inc. (OVAS) Stock Rating Lowered by Zacks Investment ResearchOvaScience Inc. (OVAS) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - November 19 at 11:36 PM
ETFs with exposure to OvaScience, Inc. : November 17, 2017ETFs with exposure to OvaScience, Inc. : November 17, 2017
finance.yahoo.com - November 18 at 10:44 AM
 Analysts Anticipate OvaScience Inc. (OVAS) to Post -$0.29 EPS Analysts Anticipate OvaScience Inc. (OVAS) to Post -$0.29 EPS
www.americanbankingnews.com - November 15 at 3:24 AM

SEC Filings

OvaScience (NASDAQ:OVAS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

OvaScience (NASDAQ:OVAS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

OvaScience (NASDAQ OVAS) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.